Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Randomized Vehicle Controlled Study Evaluating Safety and Bioequivalence of Generic Pimecrolimus Cream 1% and Elidel® Comparing Both Active Treatments to a Vehicle Control in Treatment of Mild to Moderate Atopic Dermatitis

NCT02791308 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT02791308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02791308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Randomized Vehicle Controlled Study Evaluating Safety and Bioequivalence of Generic Pimecrolimus Cream 1% and Elidel® Comparing Both Active Treatments to a Vehicle Control in Treatment of Mild to Moderate Atopic Dermatitis
Lead sponsor
Actavis Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
July 31, 2016
Enrollment
587 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis